Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 among patients with hepatitis B or hepatitis C: A systematic review

Hossein Mirzaie, Mohammad Vahidi, Mostafa Shokoohi, Maryam Darvishian, Hamid Sharifi, Heidar Sharafi, View ORCID ProfileMohammad Karamouzian
doi: https://doi.org/10.1101/2020.10.22.20216317
Hossein Mirzaie
1HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Vahidi
2Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mostafa Shokoohi
3Division of Social and Behavioural Health Sciences, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
1HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryam Darvishian
4Cancer Control Research, BC Cancer Research Centre, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamid Sharifi
1HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidar Sharafi
5Middle East Liver Diseases (MELD) Center, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Karamouzian
6School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
1HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohammad Karamouzian
  • For correspondence: Karamouzian.m@alumni.ubc.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background & aims Hepatic manifestations of coronavirus disease 2019 (COVID-19) are common among people infected with hepatitis B virus (HBV) and hepatitis C virus (HCV). This systematic review aimed to summarize the evidence on COVID-19 patients with HBV or HCV co-infections.

Methods We searched multiple electronic databases and preprint servers from December 1, 2019 to August 9, 2020. Studies were included if they reported quantitative empirical data on COVID-19 patients with HBV or HCV co-infections. Descriptive analyses were reported and data were narratively synthesized. Quality assessments was completed using the Joanna Briggs Institute critical appraisal tools.

Results Out of the 941 identified records, 28 studies were included. Of the eligible studies, 235 patients with COVID-19 were infected with HBV and 22 patients with HCV. Most patients were male and mean age was 49.8 and 62.8 in patients with HBV and HCV, respectively. Death proportion was 6% among COVID-19-HBV and 13% among COVID-19-HCV co-infected patients. Among COVID-19 patients, 34.1% and 76.2% reported at least one comorbidity besides HBV and HCV infections, mainly hypertension and diabetes mellites type 2. The most common COVID-19-related symptoms in both HBV and HCV groups were fever, cough and dyspnea. ICU admission was reported in 14.1% and 21.4% of individuals with HBV and HCV, respectively.

Conclusions Our findings suggest a considerable risk of morbidity and mortality among COVID-19 patients with HBV and HCV. Careful assessment of hepatic manifestations upon admission of patients could help improve health outcomes among COVID-19 patients with HBV or HCV co-infections.

Key Points

  • Hepatic manifestations of COVID-19 are common among people infected with HBV and HCV.

  • Among COVID-19 patients, 34.1% and 76.2% reported at least one comorbidity besides HBV and HCV infections.

  • The most common COVID-19-related symptoms in both HBV and HCV groups were fever, cough and dyspnea.

  • There is a considerable risk of mortality among COVID-19 patients with HBV and HCV.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NA

Clinical Protocols

https://osf.io/p4w3j/

Funding Statement

No funding was received for this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NA; This is a systematic review

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • E-mail addresses of all authors: Hossein Mirzaie: hosseinmirzaei64{at}yahoo.com

    Mohammad Vahidi: mammad.vahidi{at}gmail.com

    Mostafa Shokoohi: shokouhi.mostafa{at}gmail.com

    Maryam Darvishian: mdarvishian{at}bccrc.ca

    Hamid Sharifi: sharifihami{at}gmail.com

    Heidar Sharafi: heidarsharafi{at}gmail.com

    Mohammad Karamouzian: Karamouzian.m{at}alumni.ubc.ca

  • Funding statement: Authors received no funding to conduct this review.

  • Conflict of interest disclosure: Authors have no potential conflict of interest to declare.

  • Ethics approval statement: None required given the secondary nature of the study.

  • Patient consent statement: Not applicable given the secondary nature of the study.

  • Permission to reproduce material from other sources: Not applicable.

Data Availability

All data is presented in the paper

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted October 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 among patients with hepatitis B or hepatitis C: A systematic review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 among patients with hepatitis B or hepatitis C: A systematic review
Hossein Mirzaie, Mohammad Vahidi, Mostafa Shokoohi, Maryam Darvishian, Hamid Sharifi, Heidar Sharafi, Mohammad Karamouzian
medRxiv 2020.10.22.20216317; doi: https://doi.org/10.1101/2020.10.22.20216317
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
COVID-19 among patients with hepatitis B or hepatitis C: A systematic review
Hossein Mirzaie, Mohammad Vahidi, Mostafa Shokoohi, Maryam Darvishian, Hamid Sharifi, Heidar Sharafi, Mohammad Karamouzian
medRxiv 2020.10.22.20216317; doi: https://doi.org/10.1101/2020.10.22.20216317

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5219)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (750)
  • Geriatric Medicine (77)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (223)
  • Hematology (98)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5823)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (94)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (854)
  • Public and Global Health (1994)
  • Radiology and Imaging (345)
  • Rehabilitation Medicine and Physical Therapy (157)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)